7 天
Live Science on MSN'Breakthrough' stem-cell patches stabilized woman's heart as she awaited transplantA woman with heart failure was kept alive long enough to receive a heart transplant, in part thanks to newly developed ...
2 天
HotCopper.com on MSNCynata's stem cell tech verified in peer-reviewed studyCynata Therapeutics (ASX:CYP) has had its induced pluripotent stem cell (iPSC) derived mesenchymal stem cell (MSCs) verified ...
World-renowned stem cell scientists will gather in Kyoto, Japan for the International Society for Stem Cell Research (ISSCR) ...
This is especially problematic in cases of blocked blood vessels, which can repeatedly starve large areas of the heart of ...
Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, today announced the launch of Ncyte® ...
7 天
News Medical on MSNStem cell-derived heart patches show promise for heart failure treatmentInnovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...
Scientists have discovered a potential new treatment for familial hypercholesterolemia, inspired by signs seen in the Mona ...
Large language models (LLMs) possess a kind of digital pluripotency—a term borrowed from biology, describing how stem cells ... these tools. "Pluripotent AI" does not diminish human creativity ...
As the most important muscle in our body, any serious issues with our heart are considered critical and reason for ...
Ncardia, a leading human induced pluripotent stem cell (hiPSC) technology company, today announced the launch of Ncyte® Heart ...
Results from rhesus macaques provide solid ground for a first-in-human investigation of heart repair with stem cell-derived ...
Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果